BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9556603)

  • 21. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
    Chen PE; Geballe MT; Katz E; Erreger K; Livesey MR; O'Toole KK; Le P; Lee CJ; Snyder JP; Traynelis SF; Wyllie DJ
    J Physiol; 2008 Jan; 586(1):227-45. PubMed ID: 17962328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site.
    Grimwood S; Le Bourdellès B; Whiting PJ
    J Neurochem; 1995 Feb; 64(2):525-30. PubMed ID: 7830044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL; Larson HC; Morrisett RA; Monaghan DT
    Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.
    Williams K; Chao J; Kashiwagi K; Masuko T; Igarashi K
    Mol Pharmacol; 1996 Oct; 50(4):701-8. PubMed ID: 8863813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit.
    Ivanovic A; Reiländer H; Laube B; Kuhse J
    J Biol Chem; 1998 Aug; 273(32):19933-7. PubMed ID: 9685327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits.
    Wafford KA; Bain CJ; Le Bourdelles B; Whiting PJ; Kemp JA
    Neuroreport; 1993 Sep; 4(12):1347-9. PubMed ID: 7903167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue.
    Ronald KM; Mirshahi T; Woodward JJ
    J Biol Chem; 2001 Nov; 276(48):44729-35. PubMed ID: 11572853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
    Becker J; Li Z; Noe CR
    Eur J Biochem; 1998 Sep; 256(2):427-35. PubMed ID: 9760184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly.
    Schüler T; Mesic I; Madry C; Bartholomäus I; Laube B
    J Biol Chem; 2008 Jan; 283(1):37-46. PubMed ID: 17959602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeant ion effects on external Mg2+ block of NR1/2D NMDA receptors.
    Qian A; Johnson JW
    J Neurosci; 2006 Oct; 26(42):10899-910. PubMed ID: 17050728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
    Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
    Zhong J; Gribkoff VK; Molinoff PB
    Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
    Erreger K; Geballe MT; Kristensen A; Chen PE; Hansen KB; Lee CJ; Yuan H; Le P; Lyuboslavsky PN; Micale N; Jørgensen L; Clausen RP; Wyllie DJ; Snyder JP; Traynelis SF
    Mol Pharmacol; 2007 Oct; 72(4):907-20. PubMed ID: 17622578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ
    J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA; Reynolds IJ
    J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
    Chen N; Moshaver A; Raymond LA
    Mol Pharmacol; 1997 Jun; 51(6):1015-23. PubMed ID: 9187268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.